$AKRX Recent News
Post# of 102456
Posted On: 09/23/2014 11:23:06 AM
$AKRX Recent News
Speculators live by the sword, die by the sword
3:13 p.m. July 8, 2014
- The Trading Deck
Dow, Nasdaq nail the breakout point
10:36 a.m. June 27, 2014
- Michael Ashbaugh
From tiny Akorns grow mighty oaks?
11:03 a.m. Nov. 21, 2013
- The Trading Deck
Rail-Splitter's top small-cap bets are worth watching
12:34 p.m. Nov. 4, 2013
- Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash
8:02 a.m. Aug. 27, 2013
- MarketWatch.com
Monday’s biggest gaining and declining stocks
4:20 p.m. July 23, 2012
- MarketWatch
Corrective bounce, or sustainable upturn?
10:59 a.m. June 6, 2012
- Michael Ashbaugh
Charting a bearish double top
12:11 p.m. May 15, 2012
- Michael Ashbaugh
Charting a bearish double top
11:45 a.m. May 15, 2012
- Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks
6:02 p.m. March 7, 2012
- Sue Chang
Tuesday’s biggest gaining and declining stocks
5:23 p.m. March 6, 2012
- MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks
8:00 a.m. March 6, 2012
- MarketWatch
S&P 500 scratches out three-year high
12:07 p.m. March 2, 2012
- Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance
7:46 a.m. Feb. 10, 2012
- MarketWatch
S&P 500 vies for positive 2011 finish
12:09 p.m. Dec. 23, 2011
- Michael Ashbaugh
S&P, Nasdaq retest major support
12:51 p.m. Dec. 12, 2011
- Michael Ashbaugh
U.S. markets survive test of major support
10:57 a.m. Nov. 2, 2011
- Michael Ashbaugh
Akorn rallies on earnings, M&A deal
1:59 p.m. Aug. 2, 2011
- Val Brickates Kennedy
Drug stocks slip; Emergent rallies
1:28 p.m. May 26, 2011
- Val Brickates Kennedy
Drug stocks gain; Derma, Elan climb
3:51 p.m. May 25, 2011
- Val Brickates Kennedy
Acquisition-Hungry Akorn Sets Up Potential Buy Area
5:10 p.m. Sept. 22, 2014
- Investors Business Daily
Analysts Are Warming to These 5 Stocks
9:25 a.m. Sept. 22, 2014
- InvestorPlace.com
IBD 50: Akorn Aims For $1 Billion In Sales
5:35 p.m. Sept. 19, 2014
- Investors Business Daily
IBD 50 Stocks Setting Up, Including These 5 Medicals
5:35 p.m. Sept. 19, 2014
- Investors Business Daily
Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog
4:30 p.m. Sept. 18, 2014
- Zacks.com
Will Drugmaker Akorn Have A Healthy Bounce Up?
11:09 a.m. Sept. 18, 2014
- Investors Business Daily
Stocks with Upgraded Broker Ratings - Screen of the Week
3:57 a.m. Sept. 16, 2014
- Zacks.com
AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog
5:05 p.m. Sept. 12, 2014
- Zacks.com
5 Top Stocks With Rising Earnings Estimates
7:02 a.m. Sept. 12, 2014
- Investors Business Daily
Wall Street Breakfast: EU Places New Sanctions On Russia, U.S. To Follow
6:32 a.m. Sept. 12, 2014
- Seeking Alpha
Akorn In Second Test Of 10-Week Line
5:09 p.m. Sept. 11, 2014
- Investors Business Daily
Akorn reportedly eyeing tax inversion deal
4:07 p.m. Sept. 11, 2014
- Seeking Alpha
Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog
4:45 p.m. Sept. 10, 2014
- Zacks.com
10 Stocks with 5-Year Returns of 1,500%-Plus
5:10 a.m. Sept. 10, 2014
- InvestorPlace.com
Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog
5:20 p.m. Sept. 8, 2014
- Zacks.com
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog
5:05 p.m. Sept. 5, 2014
- Zacks.com
Salix, Gilead Among 5 Top Medical Leaders To Watch
4:06 p.m. Sept. 5, 2014
- Investors Business Daily
Actavis' Gastrointestinal Drug Under FDA Priority Review - Analyst Blog
4:30 p.m. Sept. 4, 2014
- Zacks.com
Will This Price Target Increase Help Akorn (AKRX) Stock Today?
9:27 a.m. Sept. 4, 2014
- TheStreet.com
Akorn (AKRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
8:54 a.m. Sept. 3, 2014
- Zacks.com
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma
9:25 a.m. Sept. 8, 2014
- PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn
8:30 a.m. Sept. 5, 2014
- PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm
8:51 a.m. Aug. 12, 2014
- GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed
9:20 a.m. Aug. 7, 2014
- PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results
6:05 a.m. Aug. 5, 2014
- GlobeNewswire
Global Parkinson%s Disease Market 2014-2018
6:42 p.m. July 28, 2014
- PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information
11:34 a.m. July 15, 2014
- GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt
6:50 a.m. July 2, 2014
- PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics
6:40 a.m. June 27, 2014
- PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant
11:11 a.m. June 20, 2014
- BusinessWire - BZX
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President,
Business Development
4:05 p.m. June 16, 2014
- BusinessWire - BZX
Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte
8:00 a.m. June 5, 2014
- PR Newswire - PRF
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co.
7:20 a.m. May 16, 2014
- PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn
11:30 a.m. May 9, 2014
- PR Newswire - PRF
Akorn to Acquire VersaPharm for $440 Million
9:19 a.m. May 9, 2014
- BusinessWire - BZX
Akorn Reports 2014 First Quarter Results
7:03 a.m. May 6, 2014
- BusinessWire - BZX
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF
Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF
Akorn Completes Acquisition of Hi-Tech Pharmacal
9:21 a.m. April 17, 2014
- BusinessWire - BZX
Repligen Corporation Set to Join the S&P SmallCap 600
5:53 p.m. April 15, 2014
- PR Newswire - PRF
Speculators live by the sword, die by the sword
3:13 p.m. July 8, 2014
- The Trading Deck
Dow, Nasdaq nail the breakout point
10:36 a.m. June 27, 2014
- Michael Ashbaugh
From tiny Akorns grow mighty oaks?
11:03 a.m. Nov. 21, 2013
- The Trading Deck
Rail-Splitter's top small-cap bets are worth watching
12:34 p.m. Nov. 4, 2013
- Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash
8:02 a.m. Aug. 27, 2013
- MarketWatch.com
Monday’s biggest gaining and declining stocks
4:20 p.m. July 23, 2012
- MarketWatch
Corrective bounce, or sustainable upturn?
10:59 a.m. June 6, 2012
- Michael Ashbaugh
Charting a bearish double top
12:11 p.m. May 15, 2012
- Michael Ashbaugh
Charting a bearish double top
11:45 a.m. May 15, 2012
- Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks
6:02 p.m. March 7, 2012
- Sue Chang
Tuesday’s biggest gaining and declining stocks
5:23 p.m. March 6, 2012
- MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks
8:00 a.m. March 6, 2012
- MarketWatch
S&P 500 scratches out three-year high
12:07 p.m. March 2, 2012
- Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance
7:46 a.m. Feb. 10, 2012
- MarketWatch
S&P 500 vies for positive 2011 finish
12:09 p.m. Dec. 23, 2011
- Michael Ashbaugh
S&P, Nasdaq retest major support
12:51 p.m. Dec. 12, 2011
- Michael Ashbaugh
U.S. markets survive test of major support
10:57 a.m. Nov. 2, 2011
- Michael Ashbaugh
Akorn rallies on earnings, M&A deal
1:59 p.m. Aug. 2, 2011
- Val Brickates Kennedy
Drug stocks slip; Emergent rallies
1:28 p.m. May 26, 2011
- Val Brickates Kennedy
Drug stocks gain; Derma, Elan climb
3:51 p.m. May 25, 2011
- Val Brickates Kennedy
Acquisition-Hungry Akorn Sets Up Potential Buy Area
5:10 p.m. Sept. 22, 2014
- Investors Business Daily
Analysts Are Warming to These 5 Stocks
9:25 a.m. Sept. 22, 2014
- InvestorPlace.com
IBD 50: Akorn Aims For $1 Billion In Sales
5:35 p.m. Sept. 19, 2014
- Investors Business Daily
IBD 50 Stocks Setting Up, Including These 5 Medicals
5:35 p.m. Sept. 19, 2014
- Investors Business Daily
Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog
4:30 p.m. Sept. 18, 2014
- Zacks.com
Will Drugmaker Akorn Have A Healthy Bounce Up?
11:09 a.m. Sept. 18, 2014
- Investors Business Daily
Stocks with Upgraded Broker Ratings - Screen of the Week
3:57 a.m. Sept. 16, 2014
- Zacks.com
AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog
5:05 p.m. Sept. 12, 2014
- Zacks.com
5 Top Stocks With Rising Earnings Estimates
7:02 a.m. Sept. 12, 2014
- Investors Business Daily
Wall Street Breakfast: EU Places New Sanctions On Russia, U.S. To Follow
6:32 a.m. Sept. 12, 2014
- Seeking Alpha
Akorn In Second Test Of 10-Week Line
5:09 p.m. Sept. 11, 2014
- Investors Business Daily
Akorn reportedly eyeing tax inversion deal
4:07 p.m. Sept. 11, 2014
- Seeking Alpha
Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog
4:45 p.m. Sept. 10, 2014
- Zacks.com
10 Stocks with 5-Year Returns of 1,500%-Plus
5:10 a.m. Sept. 10, 2014
- InvestorPlace.com
Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog
5:20 p.m. Sept. 8, 2014
- Zacks.com
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog
5:05 p.m. Sept. 5, 2014
- Zacks.com
Salix, Gilead Among 5 Top Medical Leaders To Watch
4:06 p.m. Sept. 5, 2014
- Investors Business Daily
Actavis' Gastrointestinal Drug Under FDA Priority Review - Analyst Blog
4:30 p.m. Sept. 4, 2014
- Zacks.com
Will This Price Target Increase Help Akorn (AKRX) Stock Today?
9:27 a.m. Sept. 4, 2014
- TheStreet.com
Akorn (AKRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
8:54 a.m. Sept. 3, 2014
- Zacks.com
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma
9:25 a.m. Sept. 8, 2014
- PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn
8:30 a.m. Sept. 5, 2014
- PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm
8:51 a.m. Aug. 12, 2014
- GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed
9:20 a.m. Aug. 7, 2014
- PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results
6:05 a.m. Aug. 5, 2014
- GlobeNewswire
Global Parkinson%s Disease Market 2014-2018
6:42 p.m. July 28, 2014
- PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information
11:34 a.m. July 15, 2014
- GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt
6:50 a.m. July 2, 2014
- PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics
6:40 a.m. June 27, 2014
- PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant
11:11 a.m. June 20, 2014
- BusinessWire - BZX
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President,
Business Development
4:05 p.m. June 16, 2014
- BusinessWire - BZX
Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte
8:00 a.m. June 5, 2014
- PR Newswire - PRF
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co.
7:20 a.m. May 16, 2014
- PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn
11:30 a.m. May 9, 2014
- PR Newswire - PRF
Akorn to Acquire VersaPharm for $440 Million
9:19 a.m. May 9, 2014
- BusinessWire - BZX
Akorn Reports 2014 First Quarter Results
7:03 a.m. May 6, 2014
- BusinessWire - BZX
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF
Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF
Akorn Completes Acquisition of Hi-Tech Pharmacal
9:21 a.m. April 17, 2014
- BusinessWire - BZX
Repligen Corporation Set to Join the S&P SmallCap 600
5:53 p.m. April 15, 2014
- PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼